Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1999-11-19
pubmed:abstractText
Signaling through the TCR as well as engagement of costimulatory molecules are required for efficient T cell activation and progression into differentiated effector cells. The beta2 integrin LFA-1 (CD11a/CD18) has been implicated in TCR costimulation as well as in cell-cell adhesion function, but its exact role is still ambiguous. The present study focuses on the requirement for LFA-1 in CD8+ T cell activation and effector function using LFA-1-deficient cells expressing the 2C transgenic TCR as a model system. The lack of LFA-1 expression in 2C T cells resulted in severely diminished proliferative response toward allogeneic BALB/c splenocytes. Increase in TCR signaling alone by pulsing stimulators with high affinity peptides, p2Ca or QL9, had minimal effects in restoring proliferation. Addition of exogenous IL-2, however, enhanced the effect of peptide pulsing on proliferation of LFA-1-deficient 2C T cells. LFA-1-deficient 2C CTLs generated from alloantigen stimulation exhibited a defective cytotoxic activity when tested on a variety of target cells. Cytolysis could be improved, but not fully rectified by peptide pulsing of target cells. Thus, in the 2C TCR model, LFA-1 has a requisite role for optimal CD8+ T cell activation and effector function, which cannot be overcome by increasing peptide/MHC density on either the APCs or target cells, respectively.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
163
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4826-32
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:10528183-Animals, pubmed-meshheading:10528183-Antibodies, Blocking, pubmed-meshheading:10528183-Antibodies, Monoclonal, pubmed-meshheading:10528183-Antigens, CD, pubmed-meshheading:10528183-CD8-Positive T-Lymphocytes, pubmed-meshheading:10528183-Cytotoxicity, Immunologic, pubmed-meshheading:10528183-Cytotoxicity Tests, Immunologic, pubmed-meshheading:10528183-H-2 Antigens, pubmed-meshheading:10528183-Interleukin-2, pubmed-meshheading:10528183-Isoantigens, pubmed-meshheading:10528183-Lymphocyte Activation, pubmed-meshheading:10528183-Lymphocyte Function-Associated Antigen-1, pubmed-meshheading:10528183-Mice, pubmed-meshheading:10528183-Mice, Inbred BALB C, pubmed-meshheading:10528183-Mice, Inbred C57BL, pubmed-meshheading:10528183-Mice, Knockout, pubmed-meshheading:10528183-Mice, Transgenic, pubmed-meshheading:10528183-Peptides, pubmed-meshheading:10528183-Receptors, Antigen, T-Cell, pubmed-meshheading:10528183-Signal Transduction, pubmed-meshheading:10528183-T-Lymphocytes, Cytotoxic, pubmed-meshheading:10528183-Transfection, pubmed-meshheading:10528183-Tumor Cells, Cultured
pubmed:year
1999
pubmed:articleTitle
Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
pubmed:affiliation
R. W. Johnson Pharmaceutical Research Institute, San Diego, CA 92121, USA.
pubmed:publicationType
Journal Article